The SPECTRA study for transgender and gender diverse people
Treatments studied
Part of Mental health clinical trials.
This study follows transgender and gender diverse people of all ages 16 and older to learn more about their health and well-being over time. It is for those who have a diagnosis of gender incongruence and are either starting, continuing, or have stopped gender affirming therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years old or older.
- You have been diagnosed with gender incongruence (your experienced gender differs from the sex you were assigned at birth).
- You have a need for gender affirming therapy, or you are currently getting it, or you have had it in the past.
- You are able to give your informed consent to take part in the study.
- You are willing and able to follow the study instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at starting gender-affirming hormone therapy (GAHT) for transgender people who have never had these treatments before. It may help you learn whether this approach is safe and effective for your goals as you begin care.
This study looks at people who are preparing to start gender-affirming hormone treatment. It may help researchers understand what support is needed before hormones begin.
This study looks at how gender-affirming hormone therapy affects heart health, metabolism, and mental well-being in transgender adults. It aims to understand the benefits and risks to help improve care.
This study looks at how gender-affirming hormone therapy affects the heart and blood vessels in transgender people. If you've been on hormones for at least a year, researchers want to check your cardiovascular health to better understand long-term risks and benefits.
This study looks back at the medical records of transgender young people who began gender-affirming care at Strasbourg University Hospital before age 18. It helps doctors understand their experiences and improve future care.
This study looks at how gender-affirming hormone therapy affects brain health and function in transgender adults. Researchers want to understand the effects of these hormones on the brain before and after treatment begins.
Hear when a new Transgender Individuals trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.